ISHARES TR - ISHARES BIOTECH (IBB)

Historical Holders from Q1 2014 to Q3 2025

Symbol
IBB
Type / Class
Equity / ISHARES BIOTECH
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31,970,322
Holdings value
$4,620,465,363
% of all portfolios
0.01%
Number of holders
790
Number of buys
233
Number of sells
-387
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 31,970,322 $4,620,465,363 -$69,042,041 $144.37 790
2025 Q2 31,072,085 $3,936,382,892 +$47,323,412 $126.51 788
2025 Q1 31,036,041 $3,974,324,671 -$396,178,767 $127.9 825
2024 Q4 34,655,995 $4,589,497,492 +$21,795,363 $132.21 868
2024 Q3 35,367,562 $5,150,797,550 -$573,304,257 $145.6 882
2024 Q2 38,432,409 $5,277,616,107 +$719,237 $137.26 886
2024 Q1 38,635,448 $5,300,104,214 +$342,697,016 $137.22 889
2023 Q4 35,699,522 $4,849,731,034 -$440,817,654 $135.85 866
2023 Q3 38,516,647 $4,710,098,168 -$206,156,929 $122.29 828
2023 Q2 40,247,966 $5,110,298,381 -$166,074,410 $126.96 834
2023 Q1 41,326,279 $5,337,459,250 -$427,530,397 $129.16 858
2022 Q4 43,459,538 $5,705,949,548 +$647,747,421 $131.29 895
2022 Q3 39,025,913 $4,565,910,057 -$61,899,980 $116.96 818
2022 Q2 39,837,799 $4,687,241,888 -$150,124,982 $117.63 847
2022 Q1 41,398,739 $5,397,605,243 -$45,866,179 $130.3 880
2021 Q4 41,655,838 $6,352,062,969 -$354,862,874 $152.62 951
2021 Q3 43,883,136 $7,094,482,334 -$474,313,991 $161.68 847
2021 Q2 46,764,551 $7,652,437,559 -$736,351,962 $163.65 853
2021 Q1 50,916,680 $7,666,252,840 -$1,332,296,824 $150.56 833
2020 Q4 58,699,842 $8,895,917,161 +$1,047,035,345 $151.49 844
2020 Q3 54,509,238 $7,377,985,252 -$448,424,368 $135.41 775
2020 Q2 57,604,943 $7,875,097,725 +$1,185,874,028 $136.69 758
2020 Q1 47,144,066 $5,081,744,912 -$740,712,721 $107.74 660
2019 Q4 53,220,691 $6,412,231,577 -$18,208,247 $120.51 703
2019 Q3 52,786,622 $5,253,763,962 -$3,370,366 $99.5 589
2019 Q2 51,864,871 $5,656,294,624 +$177,536,052 $109.1 645
2019 Q1 49,719,281 $5,558,313,234 +$244,748,034 $111.8 663
2018 Q4 47,722,082 $4,603,357,006 -$272,152,751 $96.43 642
2018 Q3 51,627,850 $6,294,135,263 -$539,422,584 $121.94 628
2018 Q2 55,871,458 $6,137,217,009 +$257,169,455 $109.82 604
2018 Q1 54,006,104 $5,764,090,120 -$20,390,359 $106.74 607
2017 Q4 53,440,420 $5,707,270,426 +$3,314,278,601 $106.77 618
2017 Q3 19,328,962 $6,446,068,586 +$614,598,483 $333.59 581
2017 Q2 17,594,322 $5,456,889,651 +$105,134,710 $310.08 559
2017 Q1 17,210,115 $5,047,040,298 +$495,733,103 $293.27 519
2016 Q4 15,589,448 $4,135,825,810 -$145,086,739 $265.38 522
2016 Q3 16,095,177 $4,618,861,961 +$577,362,254 $289.46 460
2016 Q2 14,520,329 $3,729,151,326 -$155,020,766 $257.34 421
2016 Q1 14,816,870 $3,854,656,469 -$440,823,854 $260.81 407
2015 Q4 16,408,335 $5,547,723,107 -$1,683,021,553 $338.33 426
2015 Q3 21,207,917 $6,435,768,089 +$1,103,919,618 $303.33 408
2015 Q2 17,977,495 $6,631,337,034 -$257,488,346 $368.97 417
2015 Q1 18,655,055 $6,406,249,888 +$717,963,899 $343.43 393
2014 Q4 16,780,107 $5,090,432,479 -$691,524,112 $303.35 365
2014 Q3 18,942,767 $5,181,884,338 +$614,436,883 $273.63 313
2014 Q2 16,697,488 $4,291,448,882 -$587,475,619 $257.03 301
2014 Q1 19,090,905 $4,512,539,004 +$1,286,111,328 $236.4 287